gilead sciences inc
(GILD:Consolidated Issue Listed on NASDAQ Global Select )
John G. McHutchison M.D., FRACP
Executive Vice President of Clinical Research, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 4 different organizations across 10 different industries.|
See Board Relationships
Dr. John G. McHutchison, M.D., FRACP has been Executive Vice President of Clinical Research at Gilead Sciences Inc. since January 27, 2014. Dr. McHutchison served as Senior Vice President of Liver Disease Therapeutics at Gilead Sciences Inc. from June 2010 to January 27, 2014 and was responsible for its research and development efforts supporting its programs in liver disease, including hepatitis C. Dr. McHutchison served as Gastroenterology and Hepatology Advisor of ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
The University of Melbourne
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Olivier Brandicourt||Chief Executive Officer and Director|
|--||Compensation as of Fiscal Year 2014.|